14,500 Shares in GE HealthCare Technologies Inc. (NASDAQ:GEHC) Acquired by Polianta Ltd

Polianta Ltd acquired a new stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 14,500 shares of the company's stock, valued at approximately $1,170,000.

Several other hedge funds and other institutional investors have also made changes to their positions in GEHC. Stratos Wealth Partners LTD. lifted its position in shares of GE HealthCare Technologies by 19.4% in the fourth quarter. Stratos Wealth Partners LTD. now owns 5,076 shares of the company's stock valued at $397,000 after buying an additional 824 shares during the last quarter. Empowered Funds LLC raised its stake in GE HealthCare Technologies by 15.8% in the 4th quarter. Empowered Funds LLC now owns 27,183 shares of the company's stock valued at $2,125,000 after acquiring an additional 3,713 shares during the period. Savant Capital LLC lifted its holdings in GE HealthCare Technologies by 149.7% during the 4th quarter. Savant Capital LLC now owns 27,585 shares of the company's stock valued at $2,157,000 after purchasing an additional 16,538 shares during the last quarter. Essex Financial Services Inc. boosted its position in GE HealthCare Technologies by 9.5% during the fourth quarter. Essex Financial Services Inc. now owns 8,818 shares of the company's stock worth $689,000 after purchasing an additional 766 shares during the period. Finally, Leavell Investment Management Inc. increased its holdings in shares of GE HealthCare Technologies by 19.4% in the fourth quarter. Leavell Investment Management Inc. now owns 32,653 shares of the company's stock valued at $2,553,000 after purchasing an additional 5,297 shares during the last quarter. 82.06% of the stock is owned by institutional investors.

GE HealthCare Technologies Price Performance

Shares of GEHC traded down $0.86 during trading hours on Friday, hitting $72.25. 2,976,907 shares of the company were exchanged, compared to its average volume of 3,453,790. The company has a quick ratio of 0.83, a current ratio of 1.04 and a debt-to-equity ratio of 0.88. GE HealthCare Technologies Inc. has a fifty-two week low of $57.65 and a fifty-two week high of $94.80. The company has a market cap of $33.08 billion, a price-to-earnings ratio of 16.69, a P/E/G ratio of 3.19 and a beta of 1.14. The firm's fifty day moving average is $68.40 and its 200 day moving average is $78.41.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last announced its quarterly earnings data on Wednesday, April 30th. The company reported $1.01 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.91 by $0.10. The firm had revenue of $4.78 billion for the quarter, compared to the consensus estimate of $4.66 billion. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. The business's revenue for the quarter was up 2.7% on a year-over-year basis. During the same period in the prior year, the company posted $0.90 earnings per share. On average, equities analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies announced that its Board of Directors has authorized a share buyback plan on Wednesday, April 30th that allows the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization allows the company to buy up to 3.1% of its shares through open market purchases. Shares repurchase plans are generally an indication that the company's board believes its stock is undervalued.

GE HealthCare Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, May 15th. Investors of record on Friday, April 25th were paid a $0.035 dividend. The ex-dividend date was Friday, April 25th. This represents a $0.14 dividend on an annualized basis and a yield of 0.19%. GE HealthCare Technologies's dividend payout ratio (DPR) is 2.95%.

Analyst Upgrades and Downgrades

Several brokerages recently commented on GEHC. Wall Street Zen raised shares of GE HealthCare Technologies from a "hold" rating to a "buy" rating in a report on Saturday, May 31st. Piper Sandler reduced their price objective on GE HealthCare Technologies from $104.00 to $88.00 and set an "overweight" rating for the company in a report on Wednesday, April 23rd. Wells Fargo & Company lowered their target price on GE HealthCare Technologies from $103.00 to $89.00 and set an "overweight" rating on the stock in a research note on Thursday, May 1st. UBS Group upgraded GE HealthCare Technologies from a "sell" rating to a "neutral" rating and reduced their price target for the company from $74.00 to $73.00 in a research note on Monday, May 5th. Finally, Citigroup lowered their price objective on GE HealthCare Technologies from $105.00 to $86.00 and set a "buy" rating on the stock in a research report on Wednesday, April 30th. Three investment analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, GE HealthCare Technologies currently has an average rating of "Moderate Buy" and an average target price of $88.27.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.